4 Bold Predictions for the Rest of 2021 By Steve Fernandez, Research Analyst, Strategic Fortunes | | Dear Smart Investor, The first half of 2021 is now behind us. And to get an idea of where the market is going, we must first reflect on where it has been. At the end of last year, I made four big predictions for 2021. - A devaluation in the U.S. dollar will spark a stock market rally.
Who wasn’t a dollar bear coming into this year? The government was handing out money left and right, and interest rates were near all-time lows.
Although the U.S. Dollar Index (DXY) didn’t reach my low-$80s target price, it has shown weakness, hovering between $89 and $92.
The stock market rallied nonetheless. The S&P 500 Index currently stands at 4,385, well above my 4,300 target for the end of 2021.
Growth stocks were a nonfactor for the bulk of the rally. In fact, S&P 500 value stocks were outperforming S&P 500 growth stocks by a ratio of 5-to-1 until mid-May.
But money is now piling back into growth stocks. So much so that growth is now outperforming value on the year.
With the growth trade back in play, I am now revising my year-end target for the S&P 500 from 4,300 to 4,700. The S&P 500 Will Hit 4,700 This Year 
(Source: Bloomberg.)
$12 Trillion “Tech Takeover” by 2035
One expert said a single technology is as “central to the next phase of human existence as electricity was 100 years ago.” And one California company is at the forefront of it all. They hold the key to rolling this “secret sauce” out to the masses. Full story here.
The Next 6 Months Will Be Exciting -
Biotech stocks will lead the market.
Right out of the gate, biotech stocks were running hot. The Nasdaq Biotech Index (NBI) rallied 15% before reversing in early February. This was around the time the market started getting spooked by a rise in inflation. But money is flooding back into the sector as investors have gotten excited about recent breakthroughs. Investors Are Pouring Money Into Biotech 
(Source: Bloomberg.) Biotech company Intellia reported promising data from its revolutionary CRISPR trial. The innovative technology has now been administered directly inside the human body. The Food and Drug Administration approved Biogen's Alzheimer's drug, marking the first approval for an Alzheimer's therapy in over 17 years. More developments will unfold to end the year, and I expect the biotech sector to stay hot as they play out. -
Chinese stocks will outperform U.S. stocks. The market favored Chinese stocks to start the year, and they rose 10% by mid-February. But China’s government threatened some of its nation’s biggest companies, causing Chinese stocks to crater over the following months. Chinese Stocks (Purple) vs. U.S. Stocks (Black) 
(Source: Bloomberg.) Although Chinese stocks are slowly rebounding, I expect gains to be slow unless the government eases its scrutiny on technology companies. We all know the Chinese government is unpredictable, so it’s impossible to know exactly when this will occur. -
Small-cap stocks will outperform large-cap stocks.
U.S. small-cap stocks started the year strong, gaining 20% through mid-March. At that point, they were outperforming large caps by a ratio of 3-to-1. Small caps have since consolidated, and large caps have made up ground, putting the two groups neck and neck. Small Caps (Purple) vs. Large Caps (Black) 
(Source: Bloomberg.) But I expect small caps will outperform to end the year, in part thanks to the rise in retail investing. According to Goldman Sachs, retail trading activity has doubled since 2016 and now accounts for about 20% of total U.S. stock trading volume. And what do retail investors buy? Small caps. Institutions generally have size limitations, which prevents them from taking significant stakes in smaller companies. This leaves retail investors to control the market. With more retail trading activity, small caps will soar. I’d say my top predictions for 2021 are panning out nicely. But we have a long way to go before the end of the year, and anything could happen. So, make sure you continue to follow our daily insights to learn about the market’s profit opportunities as they arise. Regards,
Steve Fernandez
Research Analyst, Strategic Fortunes  
    Privacy Policy
Smart Profits Daily, P.O. Box 8378, Delray Beach, FL 33482.
To unsubscribe from Smart Profits Daily emails, click here.
To ensure that you receive future issues of Smart Profits Daily, please add info@mb.banyanhill.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance.
The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: http://banyanhill.com/contact-us
Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Banyan Hill Publishing expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Banyan Hill Publishing, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.
(c) 2021 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096)
| | | | | | |
No comments:
Post a Comment